JOIN
LOGIN
Deals
DealShot
Private Equity
Investment
Fundraising
Exits
Venture Capital
Investment
Fundraising
Exits
Strategic Deals
IPO
Tech
Aerospace
AI
Blockchain
Fintech
Internet
Smart Hardware
VR/AR
Industry
Consumer
Education
Entertainment
Healthcare
Mobility
Special Situations
Insights
China Expert Network
Podcasts
China Money TV
China VC Tracker
Rankings
Reports
中文版
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Privacy Policy
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
Search
Podcasts
Rankings
Money TV
DealShot
Expert Network
LOGIN
JOIN
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
China Money Network
JOIN
LOGIN
Deals
DealShot
Private Equity
Investment
Fundraising
Exits
Venture Capital
Investment
Fundraising
Exits
Strategic Deals
IPO
Tech
Aerospace
AI
Blockchain
Fintech
Internet
Smart Hardware
VR/AR
Industry
Consumer
Education
Entertainment
Healthcare
Mobility
Special Situations
Insights
China Expert Network
Podcasts
China Money TV
China VC Tracker
Rankings
Reports
中文版
Tag: Suzhou
Robert Walters China Salary Survey 2023: Easing of Epidemic Control: Recruitment...
PR Newswire
-
March 2, 2023 — 14:00
Commercialization of Gene Therapy is coming soon: Neurophth Completes Patient Enrollment...
PR Newswire
-
February 21, 2023 — 21:30
Eluminex Biosciences Announces Completion of Initial Enrollment in Part A of...
PR Newswire
-
February 15, 2023 — 01:00
Qiming Venture Partners’ portfolio company LanzaTech Lists on Nasdaq
PR Newswire
-
February 11, 2023 — 13:47
Celebrate the Lantern Festival and Enjoy Lanterns in the Glittering Ancient...
PR Newswire
-
February 11, 2023 — 10:21
Qiming Venture Partners Backed Structure Therapeutics Successfully Debuts on Nasdaq
PR Newswire
-
February 4, 2023 — 14:45
Gracell Biotechnologies Announces FDA Clearance of the IND Application for Phase...
PR Newswire
-
February 3, 2023 — 20:30
China’s First and Only Approved Third-Generation BCR-ABL Inhibitor Olverembatinib Included into...
PR Newswire
-
January 19, 2023 — 11:45
Village welcomes riches by developing tourism
PR Newswire
-
January 7, 2023 — 23:00
Innovent Presents Phase 1b Clinical Data of IBI188 (Anti-CD47 Monoclonal Antibody)...
PR Newswire
-
December 11, 2022 — 08:00
Gracell Biotechnologies Presents Clinical Data for FasTCAR-T GC012F for High Risk,...
PR Newswire
-
December 11, 2022 — 07:15
ZEISS Makes Fifth Appearance at CIIE, Placing Great Effort in Localization...
PR Newswire
-
November 6, 2022 — 14:06
Harbour BioMed Announces Dosing of First Patient in Phase I Trial...
PR Newswire
-
October 20, 2022 — 16:20
Innovent Announces Phase Ib Results of Higher-dose Mazdutide (IBI362) in Chinese...
PR Newswire
-
October 17, 2022 — 08:00
Sciwind Biosciences and SynerK Enter into Research Partnership to Discover and...
PR Newswire
-
September 27, 2022 — 08:00
Admiring the Moon and Enjoying Mooncakes……Chinese Youth Preserving Romantic Festive Customs
PR Newswire
-
September 11, 2022 — 08:30
The 2022 Yangtze River Culture Festival kicked off in Zhangjiagang
PR Newswire
-
August 31, 2022 — 13:01
Ascentage Pharma Announces 2022 Interim Results
PR Newswire
-
August 27, 2022 — 00:47
Sirnaomics Advances GalAhead(TM)-Based RNAi Therapeutics for Treatment of Complement-Related Diseases
PR Newswire
-
August 26, 2022 — 21:54
WuXi Biologics Reports Strong 2022 Interim Results
PR Newswire
-
August 17, 2022 — 21:32
Kintor Pharma Announces Completion of Subject Enrollment and Dosing in Phase...
PR Newswire
-
August 9, 2022 — 17:00
Transcenta to Present Interim Safety and Efficacy Data of the TST001...
PR Newswire
-
July 28, 2022 — 08:00
Ascentage Pharma and Tanner Pharma Group Initiate a Global Innovative Named...
PR Newswire
-
July 25, 2022 — 21:59
China CDE Grants Breakthrough Therapy Designation (BTD) to Neurophth’s NR082 in...
PR Newswire
-
July 15, 2022 — 21:00
CStone Announces the NDA Approval of GAVRETO® (pralsetinib) for the Treatment...
PR Newswire
-
July 15, 2022 — 08:02
ASCO 2022 | Ascentage Pharma Releases Updated Data Demonstrating Lisaftoclax’s (APG-2575)...
PR Newswire
-
June 8, 2022 — 08:00
ASCO 2022 | Ascentage Pharma Releases for the First Time Results...
PR Newswire
-
June 8, 2022 — 08:00
CStone presents updated results of anti-PD-1 antibody nofazinlimab in combination with...
PR Newswire
-
June 5, 2022 — 08:02
CStone presents clinical results of sugemalimab in patients with relapsed or...
PR Newswire
-
June 4, 2022 — 08:02
Gracell Biotechnologies Schedules Clinical Update Call After EHA2022
PR Newswire
-
June 3, 2022 — 23:00
Innovent Appoints Mr. Gary Zieziula as Independent Non-executive Director
PR Newswire
-
June 1, 2022 — 08:00
Want to see more data? Registered subscribers can see all the data.
Register Now!
Posting....